National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1165506

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1165506
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-03-05
Onset:2021-03-06
Submitted:0000-00-00
Entered:2021-04-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET1831 / 1 LA / OT

Administered by: Other      Purchased by: ??
Symptoms: Asthenia, Body temperature, Chest pain, Blood pressure measurement

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-03-06
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Diabetes mellitus insulin-dependent; Hypertension; OA knee (knee arthrosis)
Preexisting Conditions: Medical History/Concurrent Conditions: Weakness; Wheelchair user
Allergies:
Diagnostic Lab Data: Test Date: 20210305; Test Name: blood pressure; Result Unstructured Data: Test Result:140/80 mmHg; Test Date: 20210305; Test Name: body temperature; Result Unstructured Data: Test Result:36.4 Centigrade
CDC 'Split Type': HUPFIZER INC2021354240

Write-up: weakness; chest pain; This is a spontaneous report from a contactable physician downloaded from a regulatory authority- WEB. E2B Authority Number is HU-OGYI-145721. An 81-year-old female patient received her 1st dose of BNT162B2 (COMIRNATY, lot number ET1831, expiry date: unknown) at 0.3 ml single dose intramuscular in left upper arm on 05Mar2021 for COVID-19 immunisation. Medical history included knee arthrosis, hypertension, and diabetes mellitus insulin-dependent, all ongoing. Before vaccination, the patient was already very weak; she could be travelled by wheelchair although her diseases were balanced by her current pharmacotherapy. Based on the vaccinating doctor, there was no contraindication of vaccination, she was cardio-pulmonary compensated, her blood pressure and body temperature were normal (140/80 Hgmm and 36.4 degree C, respectively). Concomitant drug was not provided. During the half-hour observation period, no reaction was observed. On the next day in the afternoon, the patient became weak, later, she experienced chest pain and died at her home. Based on the opinions of the patient''s vaccinating physician and family doctor, the death was not related to the vaccination but could be due to a cardiac event. Autopsy has been done, the result is unknown. Sender Comment: Weakness is an expected adverse event of COMIRNATY, however, the patient was already reported to be weak before vaccination. Time to onset was one day. Causality between the weakness, and resulting death and COMIRNATY is not assessable. The case is serious because the patient has died. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: weakness; chest pain

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1165506&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166